-+ 0.00%
-+ 0.00%
-+ 0.00%

Avidity Biosciences Receives Orphan Drug Designation In Japan For Delpacibart Etedesiran For Myotonic Dystrophy Type 1

Benzinga·04/08/2025 13:03:25
Listen to the news

Del-desiran first-ever investigational treatment for DM1 to receive Orphan Drug designation in Japan